Activation of β2-Adrenergic Receptor Promotes Growth and Angiogenesis in Breast Cancer by Down-regulating PPARγ
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Chronic stress and related hormones are key in cancer progression. Peroxisome proliferator- activated receptor ! (PPAR!) and its agonists was reported that inducing anti-tumor effect. However, the function of PPAR! in pro-tumorigenic effects induced by chronic stress in breast cancer remains unknown. Herein, we have characterized a novel role of PPAR! and vascular endothelial growth factor (VEGF)/fibroblast growth factor 2 (FGF2) signals in breast cancer promoted by chronic stress. Materials and Methods We performed experiments in vivo and in vitro and used bioinformatics data to evaluate the therapeutic potential of PPAR! in breast cancer promoted by stress. Results Chronic stress significantly inhibited the PPAR! expression and promoted breast cancer in vivo. VEGF/FGF2-mediated angiogenesis increased in the chronic stress group compared to the control group. PPAR! agonist pioglitazone (PioG) injection offset the pro-tumorigenic effect of chronic stress. Moreover, specific "2-adrenergic receptor ("2R) antagonist ICI11- 8551 inhibited the effect of chronic stress. In vitro, norepinephrine (NE) treatment had a similar tendency to chronic stress. The effect of NE was mediated by the "2R/adenylate cyclase signaling pathway and suppressed by PioG. PPAR! suppressed VEGF/FGF2 through reactive oxygen species inhibition. Bioinformatics data confirmed that there was a low PPAR! expression in breast invasive carcinoma. Lower PPAR! was associated with a significantly worse survival. Conclusion "2R activation induced by chronic stress and related hormones promotes growth and VEGF/ FGF2-mediated angiogenesis of breast cancer by down-regulating PPAR!. Our findings hint that " receptor and PPAR! as two target molecules and the novel role for their agonists or antagonists as clinical medicine in breast cancer therapy.
Abstract
Purpose Chronic stress and related hormones are key in cancer progression. Peroxisome proliferator- activated receptor ! (PPAR!) and its agonists was reported that inducing anti-tumor effect. However, the function of PPAR! in pro-tumorigenic effects induced by chronic stress in breast cancer remains unknown. Herein, we have characterized a novel role of PPAR! and vascular endothelial growth factor (VEGF)/fibroblast growth factor 2 (FGF2) signals in breast cancer promoted by chronic stress. Materials and Methods We performed experiments in vivo and in vitro and used bioinformatics data to evaluate the therapeutic potential of PPAR! in breast cancer promoted by stress. Results Chronic stress significantly inhibited the PPAR! expression and promoted breast cancer in vivo. VEGF/FGF2-mediated angiogenesis increased in the chronic stress group compared to the control group. PPAR! agonist pioglitazone (PioG) injection offset the pro-tumorigenic effect of chronic stress. Moreover, specific "2-adrenergic receptor ("2R) antagonist ICI11- 8551 inhibited the effect of chronic stress. In vitro, norepinephrine (NE) treatment had a similar tendency to chronic stress. The effect of NE was mediated by the "2R/adenylate cyclase signaling pathway and suppressed by PioG. PPAR! suppressed VEGF/FGF2 through reactive oxygen species inhibition. Bioinformatics data confirmed that there was a low PPAR! expression in breast invasive carcinoma. Lower PPAR! was associated with a significantly worse survival. Conclusion "2R activation induced by chronic stress and related hormones promotes growth and VEGF/ FGF2-mediated angiogenesis of breast cancer by down-regulating PPAR!. Our findings hint that " receptor and PPAR! as two target molecules and the novel role for their agonists or antagonists as clinical medicine in breast cancer therapy.
참고문헌 (37)
- Heidt T, "Chronic variable stress activates hematopoietic stem cells", Nat Med, 20, pp.754~758 (2014)
- Cole SW, "Nervous system regulation of the cancer genome", Brain Behav Immun., 30(Suppl), pp.S10~S18 (2013)
- Thaker PH, "Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma", Nat Med, 12, pp.939~944 (2006)
- Watkins JL, "Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer", Cancer, 121, pp.3444~3451 (2015)
- Nilsson MB, "Stress hormones promote EGFR inhibitor resistance in NSCLC:Implications for combinations with beta-blockers", Sci Transl Med, 9, pp.eaao4307~ (2017)
- Jun-fang Qin, "Adrenergic receptor β2 activation by stress promotes breast cancer progression through macrophages M2 polarization in tumor microenvironment", BMB Reports, 48(5), pp.295~300 (2015), 생화학분자생물학회
- Kim-Fuchs C, "Chronic stress accelerates pancreatic cancer growth and invasion : a critical role for beta-adrenergic signaling in the pancreatic microenvironment", Brain Behav Immun, 40, pp.40~47 (2014)
- 권경아, "Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer", Cancer Research and Treatment, 48(1), pp.198~207 (2016), 대한암학회[DOI]
- Aljada A, "PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF-and VEGFmediated angiogenesis", Angiogenesis, 11, pp.361~367 (2008)
- Shigeto T, "Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer", Oncol Rep, 18, pp.833~840 (2007)
- Messmer D, "A selective novel peroxisome proliferator-activated receptor(PPAR)-alpha antagonist induces apoptosis and inhibits proliferation of CLL cells in vitro and in vivo", Mol Med, 21, pp.410~419 (2015)
- 홍온유, "Troglitazone Inhibits Matrix Metalloproteinase-9 Expression and Invasion of Breast Cancer Cell through a Peroxisome Proliferator-Activated Receptor γ- Dependent Mechanism", Journal of Breast Cancer, 21(1), pp.28~36 (2018), 한국유방암학회
- Lindgren EM, "Noradrenaline represses PPAR(peroxisome-proliferator-activated receptor)gamma2 gene expression in brown adipocytes : intracellular signalling and effects on PPARgamma2 and PPARgamma1 protein levels", Biochem J, 382, pp.597~606 (2004)
- Guo M, "Role of the adipose PPARgamma-adiponectin axis in susceptibility to stress and depression", anxiety-related behaviors, 2017, pp.22, 1056~1068
- Huber S, "Evaluation of !2-pioglitazone, an analogue of pioglitazone, on colon cancer cell survival : evidence of drug treatment association with autophagy and activation of the Nrf2", Keap1 pathway, 2014, pp.45, 426~438
- Hsiao PJ, "Pioglitazone enhances cytosolic lipolysis, beta-oxidation and autophagy to ameliorate hepatic steatosis", Sci Rep, 7, pp.9030~ (2017)
- Carmeliet P, "Angiogenesis in cancer and other diseases", Nature, 407, pp.249~257 (2000)
- Lutgendorf SK, "Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines", Clin Cancer Res, 9, pp.4514~4521 (2003)
- Srivastava N, "Inhibition of cancer cell proliferation by PPARgamma is mediated by a metabolic switch that increases reactive oxygen species levels", Cell Metab, 20, pp.650~661 (2014)
- Ushio-Fukai M, "Redox signaling in angiogenesis : role of NADPH oxidase", Cardiovasc Res, 71, pp.226~235 (2006)
- Li JH, "starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data", Nucleic Acids Res, 42, pp.D92~7 (2014)
- Tang Z, "GEPIA : a web server for cancer and normal gene expression profiling and interactive analyses", Nucleic Acids Res, 45, pp.W98~W102 (2017)
- Qin J, "Effect of hormones from adrenal gland on breast cancer metastasis in mice", Cancer Res Prev Treat, 43, pp.1013~1017 (2016)
- Nasir A, "Nutrigenomics : epigenetics and cancer prevention : a comprehensive review", Crit Rev Food Sci Nutr, 60, pp.1375~1387 (2020)
- Hill EM, "Women with ovarian cancer : examining the role of social support and rumination in posttraumatic growth, psychological distress, and psychological well-being", J Clin Psychol Med Settings, 24, pp.47~58 (2017)
- Botteri E, "Therapeutic effect of beta-blockers in triplenegative breast cancer postmenopausal women", Breast Cancer Res Treat, 140, pp.567~575 (2013)
- Wallukat G, "The beta-adrenergic receptors", Herz, 27, pp.683~690 (2002)
- Chen HY, "Synergism between cAMP and PPARgamma signalling in the initiation of UCP1gene expression in HIB1B brown adipocytes", PPAR Res, 2013, pp.476049~ (2013)
- Luz AL, "The high-production volume fungicide pyraclostrobin induces triglyceride accumulation associated with mitochondrial dysfunction, and promotes adipocyte differentiation independent of PPARgamma activation, in 3T3-L1 cells", Toxicology, 393, pp.150~159 (2018)
- Pineda-Belmontes CP, "Genetic polymorphisms of PPAR gamma, arsenic methylation capacity and breast cancer risk in Mexican women", Salud Publica Mex, 58, pp.220~227 (2016)
- Giaginis C, "Expression of peroxisome proliferator activated receptor-gamma(PPAR-gamma)in human non-small cell lung carcinoma : correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients'survival", Pathol Oncol Res, 18, pp.875~883 (2012)
- Lee EJ, "Antiinflammatory and anti-oxidant mechanisms of an MMP-8inhibitor in lipoteichoic acid-stimulated rat primary astrocytes : involvement of NF-kappaB, Nrf2, and PPAR-gamma signaling pathways", J Neuroinflammation, 15, pp.326~ (2018)
- Amor S, "Peritumoral adipose tissue as a source of inflammatory and angiogenic factors in colorectal cancer", Int J Colorectal Dis, 31, pp.365~375 (2016)
- Yoshizaki T, "Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells", J Exp Clin Cancer Res, 29, pp.22~ (2010)
- Chiu M, "Deciphering the roles of thiazolidinediones and PPARgamma in bladder cancer", PPAR Res, 2017, pp.4810672~ (2017)
- Moloney JN, "ROS signalling in the biology of cancer", Semin Cell Dev Biol, 80, pp.50~64 (2018)
- Majumder A, "Hydrogen sulfide improves postischemic neoangiogenesis in the hind limb of cystathionine-beta-synthase mutant mice via PPAR-gamma", VEGF axis, 2018, pp.6, e13858~
